Saturday, July 11, 2026

Drug profile · INN

epirubicin

epirubicin (EPIRUBICIN ACCORD) is an FDA-listed pharmaceutical active ingredient. Associated with Accord Healthcare Pty..

TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 19
News articles 0
Drug details — epirubicin

Quick answer

epirubicin (EPIRUBICIN ACCORD) is an FDA-listed pharmaceutical active ingredient. Associated with Accord Healthcare Pty..

Key facts

INN epirubicin
Brand EPIRUBICIN ACCORD

Approval history

Authority Status Date
TGA approved
NMPA clinical trials

Pipeline programs

  1. 5-Fu/epirubicin/CTX following Docetaxel Phase 3 · Chinese Academy of · Breast Cancer
  2. CTRIAL-IE 12-01 Phase 3 · Ningbo Cancer Hospital · Patients with 1-3 positive Nodes, Hormone Receptor-Positive
  3. D926QC00001 Phase 3 · AstraZeneca · Triple Negative or Hormone Receptor low/HER2-negative Breast
  4. Epirubicin Phase 3 · Chinese Academy of · Hepatocellular Carcinoma
  5. GEICAM/2011-03_S1007 Phase 3 · Ningbo Cancer Hospital · patients with node positive breast cancer who do not have hi
  6. HCB-ONC002 Phase 3 · George Institute for · HER2-positive early breast cancer
  7. ISRCTN12053408 Phase 3 · Ningbo Cancer Hospital · Intermediate stage Hepatocellular carcinoma
  8. MK-2870-032 Phase 3 · MSD Merck Sharp · Breast Cancer: triple negative breast cancer (TNBC) and horm

Frequently asked questions

What is epirubicin?

epirubicin (EPIRUBICIN ACCORD) is an FDA-listed pharmaceutical active ingredient. Associated with Accord Healthcare Pty..

What is the brand name for epirubicin?

EPIRUBICIN ACCORD is a marketed brand name for epirubicin. Check FDA Drugs@FDA for the current US label holder and prescribing information.